Bruce Bernstein - 10 Apr 2023 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role
Director
Signature
/s/ Mitchell Arnold, attorney-in-fact
Issuer symbol
PTPI
Transactions as of
10 Apr 2023
Net transactions value
$0
Form type
4
Filing time
12 Apr 2023, 18:00:29 UTC
Previous filing
31 Mar 2023
Next filing
26 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTPI Stock Option (Right to Buy) Award $0 +39,000 $0.000000 39,000 10 Apr 2023 Common Stock 39,000 $0.9900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the "Company") through the vesting date.